Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Leukoencephalopathy-palmoplantar keratoderma syndrome is a rare, genetic epidermal disease characterized by early childhood-onset of punctate palmoplantar keratoderma in association with adult-onset leukoencephalopathy manifested by progressive tetrapyramidal syndrome and cognitive deterioration.
Biomarker and diagnostic research for leukoencephalopathy-palmoplantar keratoderma syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for leukoencephalopathy-palmoplantar keratoderma syndrome.
84 publications have been identified in PubMed for leukoencephalopathy-palmoplantar keratoderma syndrome. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (30%), and Basic Science / Preclinical (7%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 42 | 50% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:32 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
25 |
30% |
Laboratory research | 6 | 7% |
Clinical study results | 3 | 4% |
Disease patterns and progression | 3 | 4% |
Other research | 2 | 2% |
New treatment approaches | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
Rautiainen N (2026). [PMID: 41074678](https://pubmed.ncbi.nlm.nih.gov/41074678/). *Am J Med Genet A*. [Case Report / Case Series]
Saleh D (2026). [PMID: 30335335](https://pubmed.ncbi.nlm.nih.gov/30335335/). *Unknown Journal*. [Case Report / Case Series]
Sidorina A (2026). [PMID: 41429203](https://pubmed.ncbi.nlm.nih.gov/41429203/). *J Lipid Res*. [Diagnostic / Biomarker]
Chen B (2026). [PMID: 41889596](https://pubmed.ncbi.nlm.nih.gov/41889596/). *Int Med Case Rep J*. [Case Report / Case Series]
Jiang X (2026). [PMID: 41533385](https://pubmed.ncbi.nlm.nih.gov/41533385/). *JAMA Dermatol*. [Case Report / Case Series]
Nykaza I (2026). [PMID: 41621675](https://pubmed.ncbi.nlm.nih.gov/41621675/). *J Am Acad Dermatol*. [Review / Meta-Analysis]
Metze D (2026). [PMID: 42029647](https://pubmed.ncbi.nlm.nih.gov/42029647/). *Dermatopathology (Basel)*. [Basic Science / Preclinical]
Cadiravane S (2026). [PMID: 41818120](https://pubmed.ncbi.nlm.nih.gov/41818120/). *J Assoc Physicians India*. [Case Report / Case Series]
Piątkiewicz M (2026). [PMID: 41884385](https://pubmed.ncbi.nlm.nih.gov/41884385/). *Clin Cosmet Investig Dermatol*. [Review / Meta-Analysis]
Rietmann SJ (2026). [PMID: 41601192](https://pubmed.ncbi.nlm.nih.gov/41601192/). *Anim Genet*. [Case Report / Case Series]